NRIX
Nurix Therapeutics, Inc. · Healthcare · Market cap $2.7B
Insiders sold $1.8M net in the last 90 days ·4 sellers, 0 buyers· 8 of 12 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 15, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Oct 15, 2026
Hansen Gwenn
Nurix Therapeutics, Inc. (NRIX) has 36 SEC Form 4 filings (101 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Oct 15, 2026.
Inside the rolling window, 4 insiders at Nurix Therapeutics, Inc. reported no open-market purchases and 35 open-market sales totaling $5.2M. The most active filer is Chief Legal Officer Ring Christine with 18 filings. Insiders have net sold $3.5M over the trailing 6 months. The most recent open-market filing is a sale of 1,452 shares by Chief Scientific Officer Hansen Gwenn, dated Oct 15, 2026, worth $36K.
- Industry:Biotechnology
- CEO:Arthur T. Sands
- Employees:317
- HQ:Brisbane, CA, US
- IPO:2020-07-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 1,452 | $36K | Oct 15 | +4.3% | SEC ↗ | |
GREGORY JULIA PFirst filing | Director | Sale | 22,583 | $529K | Oct 14 | +9.9% | SEC ↗ |
| Chief Legal Officer | Sale | 5,786 | $134K | Oct 2 | +13.2% | SEC ↗ | |
| Chief Legal Officer | Sale | 5,787 | $149K | Sep 2 | +0.8% | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,452 | $37K | Sep 1 | -0.1% | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,356 | $109K | Aug 5 | +3.6% | SEC ↗ | |
| Chief Scientific Officer | Sale | 4,111 | $100K | Aug 5 | +3.6% | SEC ↗ | |
| Chief Financial Officer | Sale | 4,761 | $116K | Aug 5 | +3.6% | SEC ↗ | |
| Chief Legal Officer | Sale | 16,589 | $382K | Aug 3 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 2,845 | $67K | Jul 30 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 3,847 | $90K | Jul 30 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 3,847 | $90K | Jul 30 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 11,008 | $259K | Jul 2 | — | SEC ↗ | |
| Chief Scientific Officer | Sale | 5,394 | $108K | Jun 25 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 28,935 | $581K | Jun 25 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 8,148 | $135K | Jun 2 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 14,055 | $233K | May 5 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 8,148 | $138K | May 4 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 5,394 | $90K | May 1 | — | SEC ↗ | |
van Houte HansFirst in 3 months | Chief Financial Officer | Sale | 2,388 | $40K | Apr 30 | — | SEC ↗ |
| Chief Legal Officer | Sale | 3,214 | $53K | Apr 30 | — | SEC ↗ | |
Hansen GwennFirst in 3 months | Chief Scientific Officer | Sale | 3,214 | $53K | Apr 30 | — | SEC ↗ |
| Chief Legal Officer | Sale | 8,148 | $124K | Apr 2 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 8,148 | $126K | Mar 2 | — | SEC ↗ | |
| Chief Legal Officer | Sale | 14,261 | $238K | Feb 9 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does NRIX have?
Nurix Therapeutics, Inc. (NRIX) has 36 SEC Form 4 filings (101 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Oct 15, 2026.
When was the most recent SEC Form 4 filing for NRIX?
The most recent Form 4 filing for NRIX on Tracefour is dated Oct 15, 2026.
Who is the most active insider at NRIX?
The most active SEC Form 4 filer at NRIX in the rolling window is Chief Legal Officer Ring Christine, with 18 filings.
What is the net insider flow at NRIX over the last 6 months?
Over the trailing 180 days, insiders at NRIX have net sold $3.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NRIX in the current window?
Inside the rolling window, insiders at NRIX bought $0 and sold $5.2M based on SEC Form 4 filings.
Can I get alerts for NRIX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Nurix Therapeutics, Inc. (NRIX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Nurix Therapeutics, Inc. is in the Healthcare sector.